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CD4 and CD8 genes are integral indicators of T-cell
lineage commitment. New insights into the control
of expression of these genes have come from recent
reports implicating chromatin-remodelling factors in
their regulation.
The question of how gene expression is regulated
during differentiation is fundamental to many biologi-
cal systems. In the immune system one of the most
avidly studied lineage fate decisions is that occurring
during the development of the mature CD4+ and CD8+
T-cell lineages. The CD4 and CD8 molecules act as
surrogate markers for the specialized effector func-
tions of mature T cells, as well as forming part of the
receptor complex that determines the cells’ specificity
for antigen. Given that specificity and function need to
be matched for T cells to eliminate pathogens effec-
tively, it is likely that there is a common developmental
program regulating expression of CD4, CD8 and other
lineage-related genes. It is not surprising, therefore,
that the analysis of DNA regulatory elements and
nuclear proteins involved in the expression of the CD4
and CD8 genes has been the focus of considerable
attention. Several recent reports have added a new
dimension to our understanding of how these genes
are regulated by demonstrating their association with
chromatin remodelling complexes during T-cell lineage
commitment [1–3].
The mature CD4+ and CD8+ subsets arise from a
common progenitor, the CD4+CD8+ double-positive
(DP) cell which expresses both proteins simultaneously
(Figure 1). The DP subset is generated in turn from a
more immature subpopulation that expresses neither
CD4 nor CD8, known as double-negative (DN) cells.
How expression of these genes is regulated during this
developmental process in which both are first off, then
on, and finally expression of only one is retained while
the other is heritably silenced, has been the subject of
much interest (reviewed in [4,5]). For both CD4 and CD8
genes, putative control regions in the DNA have been
identified, some of which show classic enhancer func-
tions. In addition, for CD4, a silencer region appears to
be responsible for actively suppressing transcription 
in the DN and CD8+ subpopulations. An equivalent
silencer region has not been found in the CD8 loci, and
an exciting new twist in the regulation of these genes
has come from some recent studies implicating proteins
associated with chromatin-remodelling complexes in
silencing of the CD4 gene [2], but also intriguingly, in
ensuring expression of the CD8 genes [3].
The CD4 protein is the product of a single gene,
whereas the CD8 protein is encoded by two genes, α
and β, that are located within 30 kb of each other in
mouse. Most T cells express CD8αβ heterodimers, but
some subsets of lymphocytes express only CD8αα
homodimers, therefore, the two CD8 genes are
expressed co-ordinately in some cell lineages but inde-
pendently in others. For both CD4 and CD8 genes,
DNase hypersensitivity analysis suggested there were
multiple regions with potential regulatory function
(Figure 2). For CD8 many of these are located in the
intragenic region between CD8α and CD8β [6,7] and
regulate expression of both genes. For both CD4 and
CD8, a number of the cis elements were confirmed to
have enhancer function, and separate enhancers were
found to be required for expression in the immature
subpopulation and the mature subpopulation. 
For the CD8 loci, correct tissue-specific and subset-
specific expression of reporter transgenes was
achieved by inclusion of the major enhancer regions
within DNase hypersensitivity clusters II, III and IV
(Figure 2) [8,9]. In contrast, although thymocyte- and
T-cell-specific CD4 expression was achieved with
reporter constructs containing the major CD4 cis
enhancer regions E4Pro and E4DP [10,11], this expres-
sion was not regulated in a subset-specific manner
without inclusion of the silencer region, S4 [12]. It
appears that both in the earliest thymocyte subpopu-
lation — the DN cells — and in the mature CD8+ SP
population, CD4 transcription is repressed by the
interaction of factors with the silencer region. In trying
to understand the mechanisms underlying CD4 silenc-
ing, Taniuchi et al. [13] identified a core sequence
within the silencer region that inhibited CD4 transcrip-
tion in a transient transfection assay. This sequence
was used in a yeast 1-hybrid screen and this led to the
identification of a Runt domain transcription factor,
Runx, that binds to this region [2].
The Runt-related transcription factors are essential
for a number of cellular differentiation programs [14]. In
addition to the conserved Runt domain, which binds
DNA in a sequence-specific manner, the carboxy-ter-
minal regions of the Runx proteins are necessary for
the dynamic association of Runx into stable nuclear
sub-domains together with partner proteins such as
PEBP2β/CBFβ [15]. Taniuchi et al. [2] identified three
binding motifs for Runt domain factors in the CD4
silencer region, and showed that mutation of two of
these motifs in the germline resulted in full de-repres-
sion of CD4 in mature CD8+ T cells. Some de-repres-
sion was also observed in the more immature DN
subpopulation, but the amount of CD4 expression was
less than that observed in mice lacking the entire
silencer region. 
The authors went on to examine mice deficient in
Runx1, Runx2 or Runx3 specifically in the hematopoietic
lineage. While Runx2−/− lymphocytes showed normal T-
cell development, there was significant de-repression 
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of CD4 on CD8 mature T cells in the absence of Runx3,
suggesting that Runx3 may be involved in the mainte-
nance of CD4 silencing in mature T cells. Curiously the
absence of Runx3 had no effect on CD4 expression in
DN cells. In contrast, conditional deletion of Runx1 led
to de-repression of CD4 in immature DN cells but not in
mature T cells, indicating that silencer activity is regu-
lated by distinct but related proteins at these different
stages of development. This identification of Runx pro-
teins as important components of silencer function sug-
gests that the control of CD4 expression is regulated
through localization of the CD4 locus to discrete nuclear
subdomains. The observation by Chi et al. [1] that CD4
silencing is also affected by mutations in the high mobil-
ity group domain of BAF57, a DNA-binding subunit of
the BAF complex (the mammalian equivalent of the
yeast chromatin-remodelling complex SWI/SNF), firmly
establishes a role for chromatin-remodelling factors in
the regulation of CD4 gene expression.
Intriguingly, activation of CD8 gene expression has
also recently been described to involve chromatin-
remodelling factors. Mice haploinsufficient for Brg, the
ATPase subunit of the BAF complex, were shown to
have impaired expression of CD8 during thymocyte
development [1]. A similar phenotype was reported by
Harker et al. [3], in mice lacking members of the Ikaros
protein family. Ikaros−/− mice have grossly impaired
lymphoid development [16] making them unsuitable
for analyzing subtle changes in gene expression.
However, a mouse mutant that was haploinsufficient
for Ikaros and null for a related family member, Aiolos,
had no overt hematopoietic defect, but showed
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Figure 1. Regulated expression of the
CD4 and CD8 genes occurs during
differentiation of T cells in the thymus.
Progenitors enter the thymus and begin a
complex differentiation sequence in which
they must rearrange and assemble on their
surface antigen-specific T-cell receptors,
which together with the co-receptors CD4
and CD8 provide the T cell with specificity.
In addition, the cells must differentiate
genes appropriate for their mature effector
function. The most immature double-nega-
tive (DN) subpopulation does not transcribe
either CD4 or CD8. Transcription of CD4 is
repressed in part by interaction of Runx1
and the BAF protein complex with the
silencer sequence. At this point the TCRβ
locus is rearranged and cells with an in-
frame product are stimulated to proliferate
and turn on expression of both CD4 and
CD8, the latter mediated in part by the effects of an association between CD8, Ikaros family members and the Brg/BAF complex, to
become double-positive (DP) cells. At this time the TCRα locus is rearranged and DP thymocytes that are able to interact with self-
peptide–MHC complexes retain expression of the appropriate co-receptor — either CD4 if the interaction is with MHC class II or CD8 if
the interaction is with MHC class I — while turning off expression of the other. Runx3 has been shown to be involved with the CD4 silencer
at this stage to downregulate CD4 expression in the CD8 lineage. The capacity to perform specialized effector functions is enabled at the
mature CD4+ and CD8+ stage. In the periphery, the CD4 silencer is no longer required to repress CD4 expression in the CD8 subset.













DN cells DP cells




Figure 2. Diagrammatic representation of
the mouse CD4 and CD8 loci.
These maps of the CD4 locus and the CD8
loci (adapted from [5]) indicate the position
of DNase hypersensitivity sites (green
downward arrows). The transcriptional
direction of the genes is shown by the hor-
izontal arrow and the closed and open
black bars indicate coding and non-coding
exons respectively. In CD4, the enhancers
are indicated in yellow circles and the
distal enhancer E4Dis and the proximal
enhancer E4Pro are located respectively
~24kb and 13kb upstream of the transcrip-
tional start site and direct CD4 expression
in the mature single-positive subsets, while
the DP enhancer E4DP is located ~40kb
downstream and directs expression in the
immature DP subset. The CD4 promoter,
P4, is indicated by a green triangle, while
the CD4 silencer, S4, is indicated by a
black triangle. For the CD8 gene, the
DNase hypersensitive sites are located in
four clusters, CI–CIV, and the four horizon-
tal bars below the gene indicate the genomic fragments that were used to define the CD8 enhancers, E8I–IV. CD8 expression in imma-
ture DP T cells requires the presence of E8II–IV or CIII and CII, while E8I is required for CD8 expression in mature CD8+ cells.














impaired expression of CD8 during early thymocyte
differentiation. The authors further established that
there was direct binding of Ikaros to CD8 regulatory
sequences in ex vivo thymocytes [3], and that deletion
of these Ikaros-binding regions resulted in variegated
expression of CD8 during the transition from DN to DP
cells [17]. Therefore, both Ikaros family members and
Brg ATPases seem to be involved in establishing tran-
scriptionally active chromatin complexes in the CD8
loci during thymocyte differentiation, presumably by
reorganizing the chromatin structure to facilitate
accessibility of the locus. At first sight these results
appear to contradict previous reports demonstrating
that in B lymphocytes Ikaros protein and the CD8
gene co-localized with regions of heterochromatin in
which the locus is never transcribed [18], suggesting
that Ikaros might be involved in extinction of CD8
expression. However, Ikaros has been suggested to
act as either a repressor or an activator depending on
the nature of the particular higher order chromatin-
remodelling complexes with which it is associated. It
will be interesting to establish whether these com-
plexes differ between CD8-expressing and CD8-non-
expressing cells.
The finding that these remodelling complexes are
associated with genes that have distinct temporal and
stage-specific patterns of expression suggests that
dynamic restructuring of chromatin is an integral part of
the differentiation program in lymphocytes. Further-
more, it appears that this restructuring can be used
both to turn on and to repress transcription from par-
ticular loci at different times. It is likely that the ability to
separate or juxtapose sequences that are distant from
one another using particular combinations of chro-
matin-remodelling proteins provides a rapid means of
temporal gene regulation. The dynamic assembly and
disassembly of these structures may provide the flexi-
bility that is required for genes with complex expression
patterns during a developmental and differentiation
sequence. Supporting evidence for this notion came
recently from experiments that showed that in activated
T cells heterochromatin becomes more fluid allowing
for these reorganizations to take place [19]. We await
with interest the further unravelling of the specific part-
ners involved in these various chromatin-remodelling
complexes that regulate the different stages of T lym-
phocyte differentiation.
References
1. Chi, T.H., Wan, M., Zhao, K., Taniuchi, I., Chen, L., Littman, D.R.
and Crabtree, G.R. (2002). Reciprocal regulation of CD4/CD8
expression by SWI/SNF-like BAF complexes. Nature 418, 195–199.
2. Taniuchi, I., Osato, M., Egawa, T., Sunshine, M.J., Bae, S.C.,
Komori, T., Ito, Y. and Littman, D.R. (2002). Differential require-
ments for Runx proteins in CD4 repression and epigenetic silenc-
ing during T lymphocyte development. Cell 111, 621–633.
3. Harker, N., Naito, T., Cortes, M., Hostert, A., Hirschberg, S., Tolaini,
M., Roderick, K., Georgopoulos, K. and Kioussis, D. (2002). The
CD8 gene locus is regulated by the Ikaros family of proteins. Mol.
Cell 10, 1403–1415.
4. Ellmeier, W., Sawada, S. and Littman, D.R. (1999). The regulation of
CD4 and CD8 coreceptor gene expression during T cell develop-
ment. Annu. Rev. Immunol. 17, 523–554.
5. Kioussis, D. and Ellmeier, W. (2002). Decision making in the
immune system: Chromatin and CD4, CD8α and CD8β gene
expression during thymic differentiation. Nat. Rev. Immunol. 2,
909–919.
6. Hostert, A., Tolaini, M., Festenstein, R., McNeill, L., Malissen, B.,
Williams, O., Zamoyska, R. and Kioussis, D. (1997). A CD8 genomic
fragment that directs subset-specific expression of CD8 in trans-
genic mice. J. Immunol. 158, 4270–4281.
7. Kieffer, L.J., Yan, L., Hanke, J.H. and Kavathas, P.B. (1997). Appro-
priate developmental expression of human CD8 beta in transgenic
mice. J. Immunol. 159, 4907–4912.
8. Hostert, A., Garefalaki, A., Mavria, G., Tolaini, M., Roderick, K.,
Norton, T., Mee, P.J., Tybulewicz, V.L., Coles, M. and Kioussis, D.
(1998). Hierarchical interactions of control elements determine
CD8alpha gene expression in subsets of thymocytes and periph-
eral T cells. Immunity 9, 497–508.
9. Zhang, X.L., Seong, R., Piracha, R., Larijani, M., Heeney, M.,
Parnes, J.R. and Chamberlain, J.W. (1998). Distinct stage-specific
cis-active transcriptional mechanisms control expression of T cell
coreceptor CD8 alpha at double- and single-positive stages of
thymic development. J. Immunol. 161, 2254–2266.
10. Siu, G., Wurster, A.L., Duncan, D.D., Soliman, T.M. and Hedrick,
S.M. (1994). A transcriptional silencer controls the developmental
expression of the CD4 gene. EMBO J. 13, 3570–3579.
11. Adlam, M., Duncan, D.D., Ng, D.K. and Siu, G. (1997). Positive
selection induces CD4 promoter and enhancer function. Int.
Immunol. 9, 877–887.
12. Sawada, S., Scarborough, J.D., Killeen, N. and Littman, D.R. (1994).
A lineage-specific transcriptional silencer regulates CD4 gene
expression during T lymphocyte development. Cell 77, 917–929.
13. Taniuchi, I., Sunshine, M.J., Festenstein, R. and Littman, D.R.
(2002). Evidence for distinct CD4 silencer functions at different
stages of thymocyte differentiation. Mol. Cell 10, 1083–1096.
14. Tracey, W.D. and Speck, N.A. (2000). Potential roles for RUNX1 and
its orthologs in determining hematopoietic cell fate. Semin. Cell
Dev. Biol. 11, 337–342.
15. Harrington, K.S., Javed, A., Drissi, H., McNeil, S., Lian, J.B., Stein,
J.L., Van Wijnen, A.J., Wang, Y.L. and Stein, G.S. (2002). Transcrip-
tion factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate
with stationary subnuclear domains. J. Cell Sci. 115, 4167–4176.
16. Georgopoulos, K. (2002). Haematopoietic cell-fate decisions, chro-
matin regulation and ikaros. Nat. Rev. Immunol. 2, 162–174.
17. Garefalaki, A., Coles, M., Hirschberg, S., Mavria, G., Norton, T.,
Hostert, A. and Kioussis, D. (2002). Variegated expression of CD8
alpha resulting from in situ deletion of regulatory sequences. Immu-
nity 16, 635–647.
18. Brown, K.E., Guest, S.S., Smale, S.T., Hahm, K., Merkenschlager, M.
and Fisher, A.G. (1997). Association of transcriptionally silent genes
with Ikaros complexes at centromeric heterochromatin. Cell 91,
845–854.
19. Festenstein, R., Pagakis, S.N., Hiragami, K., Lyon, D., Verreault, A.,
Sekkali, B., and Kioussis, D. (2003). Modulation of heterochromatin
protein 1 dynamics in primary mammalian cells. Science 299, 719-
721.
Current Biology
R191
